ARTICLE | Company News
Atlantic Pharmaceuticals Inc. other research news
May 6, 1996 7:00 AM UTC
ATLC’s Optex Ophthalmologics Inc. subsidiary received a $100,000 Phase I SBIR from the National Eye Institute to develop Catarex as a means to remove cataracts. The technology allows for the removal o...